相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation
Jake L. Owens et al.
MOLECULAR CANCER THERAPEUTICS (2022)
ONECUT2 as a key mediator of androgen receptor-independent cell growth and neuroendocrine differentiation in castration-resistant prostate cancer
WonSeok William Choi et al.
CANCER DRUG RESISTANCE (2022)
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture
Nevin Yusufova et al.
NATURE (2021)
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
Yundong He et al.
NATURE COMMUNICATIONS (2021)
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
Roberta Sulsenti et al.
FRONTIERS IN IMMUNOLOGY (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer
Alastair Davies et al.
NATURE CELL BIOLOGY (2021)
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S. Taavitsainen et al.
NATURE COMMUNICATIONS (2021)
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
Vincenza Conteduca et al.
NPJ PRECISION ONCOLOGY (2021)
Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
William Butler et al.
PRECISION CLINICAL MEDICINE (2021)
Regenerative potential of prostate luminal cells revealed by single-cell analysis
Wouter R. Karthaus et al.
SCIENCE (2020)
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D. Nyquist et al.
CELL REPORTS (2020)
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Xinzhe Yu et al.
MOLECULAR CELL (2020)
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer
Elena Beketova et al.
CANCER RESEARCH (2020)
Generalizing RNA velocity to transient cell states through dynamical modeling
Volker Bergen et al.
NATURE BIOTECHNOLOGY (2020)
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
Baijun Dong et al.
COMMUNICATIONS BIOLOGY (2020)
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes
Jake L. Owens et al.
ISCIENCE (2020)
Prostate Cancer, Version 2.2019
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical features of neuroendocrine prostate cancer
Vincenza Conteduca et al.
EUROPEAN JOURNAL OF CANCER (2019)
Molecular model for neuroendocrine prostate cancer progression
Ruiqi Chen et al.
BJU INTERNATIONAL (2018)
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
Rahul Aggarwal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted in situ genome-wide profiling with high efficiency for low cell numbers
Peter J. Skene et al.
NATURE PROTOCOLS (2018)
Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies
Rohan N. Shah et al.
MOLECULAR CELL (2018)
RNA velocity of single cells
Gioele La Manno et al.
NATURE (2018)
Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth
X. Deng et al.
ONCOGENE (2017)
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L. Bishop et al.
CANCER DISCOVERY (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
Yinan Li et al.
ONCOTARGET (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling
Kamalika Saha et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks
Martin Fischer et al.
NUCLEIC ACIDS RESEARCH (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
Xiaotun Zhang et al.
CLINICAL CANCER RESEARCH (2015)
Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure
Chang-Deng Hu et al.
FRONTIERS IN ONCOLOGY (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Models of neuroendocrine prostate cancer
Lisa D. Berman-Booty et al.
ENDOCRINE-RELATED CANCER (2015)
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
Jennifer L. Bishop et al.
ONCOTARGET (2015)
Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells
Huan-Tian Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
Charlotte Svensson et al.
NUCLEIC ACIDS RESEARCH (2014)
deepTools: a flexible platform for exploring deep-sequencing data
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
A smart local moving algorithm for large-scale modularity-based community detection
Ludo Waltman et al.
EUROPEAN PHYSICAL JOURNAL B (2013)
Transcriptional activity of c-Jun is critical for the suppression of AR function
Chih-Chao Hsu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
Steven Kregel et al.
PLOS ONE (2013)
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Subhashini Sadasivam et al.
NATURE REVIEWS CANCER (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
A clustering approach for identification of enriched domains from histone modification ChIP-Seq data
Chongzhi Zang et al.
BIOINFORMATICS (2009)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era - What should we expect?
D Khuntia et al.
CANCER (2004)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model
PJ Kaplan-Lefko et al.
PROSTATE (2003)
分享论文
